WA People
BILL · 2013–14 SESSION · LATEST VERSION SHB 2153

HB 2153: Eosinophilic GI disorders

Concerning the treatment of eosinophilic gastrointestinal associated disorders.

Summary

  • Requires health benefit plans (including plans offered to public employees) to offer benefits or coverage for medically necessary elemental formula, regardless of delivery method, for patients diagnosed with eosinophilic gastrointestinal associated disorders.

From the Substitute House Bill Report (SHB 2153), written by the Legislature's nonpartisan staff. Read the full report ↗

Enacted Enacted · Chapter 115, Laws of 2014
  1. IntroducedJan 13, 2014
  2. Out of committeeFeb 11, 2014
  3. Passed HouseFeb 14, 2014
  4. Passed SenateMar 6, 2014
  5. GovernorMar 28, 2014
  6. LawMar 28, 2014
Prime sponsor
Cyrus Habib (D-48)
Introduced
January 13, 2014 in the House
Last action
March 28, 2014
Session law
Chapter 115, Laws of 2014
Companion bill
SB 6073
Budget
Has a fiscal note
Versions
HB 2153, SHB 2153

AN ACT Relating to the treatment of eosinophilic gastrointestinal associated disorders;

Sponsors

Prime sponsor: Cyrus Habib (D-48)

12 co-sponsors (11 Democrats, 1 Republican)

Gael Tarleton D-36Charles Ross R-14Tami Green D-28Dawn Morrell D-25Larry Springer D-45Steve Tharinger D-24Laurie Jinkins D-27Roger Goodman D-45Kevin Van De Wege D-24Judy Clibborn D-41Jake Fey D-27Marcus Riccelli D-3

Votes

House · Final Passage

Passed February 14, 2014
Version voted on: SHB 2153
85 Yea 11 Nay 0 Absent 2 Excused
PartyYeaNayAbsentExcused
Democrat53002
Republican321100
How each member voted

Yea (85)

Excused (2)

Permalink to this vote

Senate · 3rd Reading & Final Passage

Passed March 6, 2014
Version voted on: SHB 2153
49 Yea 0 Nay 0 Absent 0 Excused
PartyYeaNayAbsentExcused
Democrat25000
Republican24000
How each member voted

Yea (49)

Permalink to this vote

History

  1. Effective date 6/12/2014. (SHB 2153)
  2. Chapter 115, 2014 Laws. (SHB 2153)
  3. Governor signed. (SHB 2153)
  4. Delivered to Governor. (SHB 2153)
  5. President signed. (SHB 2153)
  6. Speaker signed. (SHB 2153)
  7. Third reading, passed; yeas, 49; nays, 0; absent, 0; excused, 0. (SHB 2153)
  8. Rules suspended. Placed on Third Reading. (SHB 2153)
  9. Placed on second reading by Rules Committee. (SHB 2153)
  10. On motion, referred to Rules. (SHB 2153)
  11. Minority; without recommendation. (SHB 2153)
  12. And refer to Ways & Means. (SHB 2153)
  13. HLTH - Majority; do pass. (SHB 2153)
  14. First reading, referred to Health Care. (SHB 2153)
  15. Third reading, passed; yeas, 85; nays, 11; absent, 0; excused, 2. (SHB 2153)
  16. Rules suspended. Placed on Third Reading. (SHB 2153)
  17. 1st substitute bill substituted. (SHB 2153)
  18. 1st substitute bill substituted.
  19. Placed on second reading by Rules Committee. (SHB 2153)
  20. Placed on second reading by Rules Committee.
  21. Passed to Rules Committee for second reading. (SHB 2153)
  22. Passed to Rules Committee for second reading.
  23. APPH - Executive action taken by committee. (SHB 2153)
  24. Minority; do not pass. (SHB 2153)
  25. APPH - Majority; do pass 1st substitute bill proposed by Health Care & Wellness. (SHB 2153)
  26. APPH - Executive action taken by committee.
  27. APPH - Majority; do pass 1st substitute bill proposed by Health Care & Wellness.
  28. Minority; do not pass.
  29. Referred to Appropriations Subcommittee on Health & Human Services. (SHB 2153)
  30. Referred to Appropriations Subcommittee on Health & Human Services.
  31. HCW - Majority; 1st substitute bill be substituted, do pass. (SHB 2153)
  32. Minority; do not pass. (SHB 2153)
  33. HCW - Executive action taken by committee.
  34. Minority; do not pass.
  35. HCW - Majority; 1st substitute bill be substituted, do pass.
  36. First reading, referred to Health Care & Wellness (Not Officially read and referred until adoption of Introduction report).
  37. Prefiled for introduction.

HB 2153 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page